World Health Organization / TENNESSEE BOARD OF PHARMACY CHAPTER / Task Force / Governor Office / Department of Commerce / Foreign Pharmacy Graduate Examination Committee / Department of Health / Attorney General Office / Federal and Drug Administration / Accreditation Council for Pharmacy Education / Public Chapter / Accreditation Council for Pharmaceutical Education / Center of Disease Control / office of General / Health Department / National Association of Boards of Pharmacy / /
Person
Jane Young / Jason Kizer / Terry Grinder / Tommy Chrisp / Charles Stephens / Bunch / Scott Denaburg / Kevin Eidson / Richard Hadden / Rebecca Moak / Joyce McDaniel / Stefan Cange / Mike Newman / Brenda Warren / Nina Smothers / Michelle Long / David Reagan / /
Position
executive director / the board investigator / Assistant General Counsel / executive director / President / Chief General Counsel / president / vice president and the executive director / Vice President / executive director and investigator / director in collaboration / board investigator / President of the board / Consultant pharmacist / administrator / Assistant Commissioner / Investigator / pharmacy investigator / Counsel / pharmacist / wholesaler / researcher / Director of OITS / Chief Medical Officer / pharmacist and pharmacy technician / commissioner / executive director / board president and the vice president / Interim Executive Director / pharmacy technician / Pharmacist Investigator / /
Product
Summary Suspension / methylprednisolone acetate / IM injection / product / drug / FDA-approved drug / /
Tennessee Board of Pharmacy Board Meeting June 5, 2013 TENNESSEE BOARD OF PHARMACY 227 French Landing, Iris Room Nashville, TN